Mucosa-associated Lymphoid Tissue Lymphoma Translocation Protein 1 (MALT-1)
Showing 1 - 25 of >10,000
Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor Stage II Extranodal Marginal
Completed
- Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- +2 more
- Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Gastric Mucosa-Associated Lymphoid Tissue Lymphoma Trial in Houston (Radiation Therapy)
Recruiting
- Gastric Mucosa-Associated Lymphoid Tissue Lymphoma
- Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Nov 9, 2021
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue,
Suspended
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +23 more
- Lenalidomide
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 23, 2022
Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin Trial in Worldwide (JNJ-67856633, Ibrutinib)
Active, not recruiting
- Leukemia, Lymphocytic, Chronic, B-Cell
- Lymphoma, Non-Hodgkin
-
Copenhagen, Denmark
- +9 more
Jan 27, 2023
Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2
Active, not recruiting
- Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
- +22 more
- External Beam Radiation Therapy
- Orbital Radiation
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma Trial in Atlanta, Columbus (drug, biological,
Completed
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +8 more
- PI3K inhibitor BKM120
- +3 more
-
Atlanta, Georgia
- +1 more
Jun 27, 2022
MALT, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma Trial in Columbus (drug, biological,
Active, not recruiting
- Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue
- +9 more
- BTK inhibitor PCI-32765
- +5 more
-
Columbus, OhioOhio State University Medical Center
Jun 27, 2022
Mantle Cell Lymphoma, Follicular Lymphoma, Splenic Marginal Zone Lymphoma Trial in Chapel Hill (CAR.k.28, Fludarabine,
Recruiting
- Mantle Cell Lymphoma
- +5 more
- CAR.k.28
- +3 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Nov 19, 2021
Lymphoma, Non-Hodgkin, Chronic Lymphocytic Leukemia Trial in Worldwide (JNJ-64264681, JNJ-67856633)
Active, not recruiting
- Lymphoma, Non-Hodgkin
- Chronic Lymphocytic Leukemia
-
Stony Brook, New York
- +27 more
Aug 11, 2022
Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +23 more
- autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jan 4, 2023
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
-
Scottsdale, Arizona
- +1 more
May 6, 2022
Non-Hodgkin's Lymphoma, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor
Recruiting
- Non-Hodgkin's Lymphoma
- +18 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Mar 11, 2021
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of
Active, not recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +22 more
- Ibrutinib
- +3 more
-
Scottsdale, Arizona
- +1 more
Aug 10, 2021
Helicobacter Pylori Infection in Patients With Chronic Tonsillits Trial in Sohag (Rapid urease test for h pylori)
Recruiting
- Helicobacter Pylori Infection in Patients With Chronic Tonsillits
- Rapid urease test for h pylori
-
Sohag, EgyptSohag university Hospital
Oct 31, 2023
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +71 more
- lenalidomide
- +8 more
-
Chicago, Illinois
- +5 more
Oct 8, 2021
Biological Insights of First Relapsed-refractory Mantle Cell
Not yet recruiting
- Mantle Cell Lymphoma
-
Milano, MI, Italy
- +29 more
Nov 11, 2021
Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma
Terminated
- Adult Grade III Lymphomatoid Granulomatosis
- +116 more
- brentuximab vedotin
- +2 more
-
Chicago, Illinois
- +2 more
Aug 30, 2021
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Helicobacter Pylori Infection Trial in Changsha (Yolk antibody and IIaprazole, Amoxicillin/ Clarithromycin/Furazolidone,
Recruiting
- Helicobacter Pylori Infection
- Yolk antibody and IIaprazole, Amoxicillin/ Clarithromycin/Furazolidone, Doxycycline, Bismuth
- +3 more
-
Changsha, Hunan, ChinaThe Third Xiangya Hospital of Central South University
Dec 6, 2022
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Burkitt Lymphoma
Completed
- Adult Grade III Lymphomatoid Granulomatosis
- +88 more
- bortezomib
- +2 more
-
Detroit, MichiganBarbara Ann Karmanos Cancer Institute
Apr 14, 2021
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +18 more
- everolimus
- +6 more
-
Scottsdale, Arizona
- +1 more
Sep 28, 2020